Paper · 42289709
Food-grade TiO2 impairs intestinal mucus barrier via disrupting the gut microbiota-ILA-mucin sulfation axis: novel insights and dietary intervention strategies.
Lei L and 10 others. J Nanobiotechnology, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Food-grade TiO2 impairs intestinal mucus barrier via disrupting the gut microbiota-ILA-mucin sulfation axis: novel insights and dietary intervention strategies. Papers, record 42289709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42289709
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Food-grade TiO2 impairs intestinal mucus barrier via disrupting the gut microbiota-ILA-mucin sulfation axis: novel insights and dietary intervention strategies.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Titanium | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Mucins | Major topic |
| Intestinal Mucosa | Major topic |
| Indoles | Major topic |
| Food Additives | Major topic |
| Animals | |
| Intestinal Barrier Function | |
| Humans | |
| Male | |
| Mice | |
| Quercetin | |
| Sulfates |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82304152 | National Natural Science Foundation of China | PubMed | ||
| 2024040801020373 | Natural Science Foundation (Exploration Project) of Wuhan City | PubMed | ||
| WX23Q28 | the Funding for Scientific Research Projects from Wuhan Municipal Health Commission | PubMed | ||
| 2023AFB392 | Natural Science Foundation of Hubei Province | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,442,097 | Intestinal mucus and their glycans: A habitat for thriving microbiota. | Cell Host Microbe | 2023 | https://conductscience.org/library/papers/37442097 | PubMed |
| 2 | 35,892,731 | Quercetin: A Molecule of Great Biochemical and Clinical Value and Its Beneficial Effect on Diabetes and Cancer. | Diseases | 2022 | https://conductscience.org/library/papers/35892731 | PubMed |
| 3 | 31,156,598 | Dietary Quercetin Increases Colonic Microbial Diversity and Attenuates Colitis Severity in Citrobacter rodentium-Infected Mice. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31156598 | PubMed |
| 4 | 40,149,849 | Quercetin: Molecular Insights into Its Biological Roles. | Biomolecules | 2025 | https://conductscience.org/library/papers/40149849 | PubMed |
| 5 | 40,909,112 | Quercetin boosts gut microbiota-driven production of isovanillic acid to alleviate colitis via enhancing intestinal barrier function. | Curr Res Food Sci | 2025 | https://conductscience.org/library/papers/40909112 | PubMed |
| 6 | 36,596,102 | Intestinal protein uptake and IgE-mediated food allergy. | Food Res Int | 2023 | https://conductscience.org/library/papers/36596102 | PubMed |
| 7 | 38,417,203 | Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice. | Microbiol Res | 2024 | https://conductscience.org/library/papers/38417203 | PubMed |
| 8 | 39,300,532 | Bacteroides uniformis degrades β-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. | Microbiome | 2024 | https://conductscience.org/library/papers/39300532 | PubMed |
| 9 | 33,976,718 | Safety assessment of titanium dioxide (E171) as a food additive. | EFSA J | 2021 | https://conductscience.org/library/papers/33976718 | PubMed |
| 10 | 37,873,559 | Quercetin ameliorates ulcerative colitis by activating aryl hydrocarbon receptor to improve intestinal barrier integrity. | Phytother Res | 2024 | https://conductscience.org/library/papers/37873559 | PubMed |
1 to 10 of 60
See all 60 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,931,691 | Does Biofunctionalization Make ZnO and TiO2 Nanoparticles Safer? A Critical Review of Their Changing Toxicological Identity. | Toxics | 2026 | https://conductscience.org/library/papers/42931691 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AHR | 196 | PubTator's text mining | https://conductscience.org/library/genes/196 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42289709
GET https://conductscience.org/api/papers/v1/42289709/references?page=2